Terry Ross has stepped down as president of Imatron, although he will remain a member of the board, focusing on strategic business development. His vacated position will not be filled, nor will his office, which Imatron has already turned into a
Terry Ross has stepped down as president of Imatron, although he will remain a member of the board, focusing on strategic business development. His vacated position will not be filled, nor will his office, which Imatron has already turned into a library.
The position of president was created in 1998 as an enticement for Ross to lead the company. The agreement then was for Ross to stay just two years, long enough to redirect Imatron toward more profitable activities. He remained longer than initially planned. But for the last six weeks Ross has been on vacation. His retirement was not announced until Ross was satisfied that the company was functioning well without him.
CEO S. Lewis Meyer has taken over the helm.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.